2014 Q2 Form 10-Q Financial Statement
#000088616314000090 Filed on August 05, 2014
Income Statement
| Concept | 2014 Q2 | 2013 Q4 | 2013 Q2 |
|---|---|---|---|
| Revenue | $10.61M | $14.74M | $9.580M |
| YoY Change | 10.73% | 8.08% | 66.84% |
| Cost Of Revenue | $1.186M | $1.320M | $1.214M |
| YoY Change | -2.31% | -43.35% | 179.08% |
| Gross Profit | $9.422M | $13.42M | $8.366M |
| YoY Change | 12.62% | 18.66% | 57.64% |
| Gross Profit Margin | 88.82% | 91.06% | 87.33% |
| Selling, General & Admin | $5.240M | $4.420M | $4.310M |
| YoY Change | 21.58% | 5.24% | 11.66% |
| % of Gross Profit | 55.61% | 32.94% | 51.52% |
| Research & Development | $2.689M | $2.370M | $2.022M |
| YoY Change | 32.99% | -4.44% | -29.05% |
| % of Gross Profit | 28.54% | 17.66% | 24.17% |
| Depreciation & Amortization | $669.0K | $700.0K | $669.0K |
| YoY Change | 0.0% | 0.0% | -1.33% |
| % of Gross Profit | 7.1% | 5.22% | 8.0% |
| Operating Expenses | $2.689M | $6.790M | $2.022M |
| YoY Change | 32.99% | 1.8% | -29.05% |
| Operating Profit | $1.358M | $6.630M | $1.514M |
| YoY Change | -10.3% | 42.89% | -183.42% |
| Interest Expense | $181.0K | -$320.0K | $453.0K |
| YoY Change | -60.04% | -56.16% | -40.55% |
| % of Operating Profit | 13.33% | -4.83% | 29.92% |
| Other Income/Expense, Net | -$117.0K | -$4.100M | $2.290M |
| YoY Change | -105.11% | 57.69% | -205.29% |
| Pretax Income | $1.241M | $2.010M | $3.804M |
| YoY Change | -67.38% | 111.58% | -195.34% |
| Income Tax | -$47.00K | $138.0K | $110.0K |
| % Of Pretax Income | -3.79% | 6.87% | 2.89% |
| Net Earnings | $1.592M | $1.869M | $6.091M |
| YoY Change | -73.86% | 75.82% | -340.85% |
| Net Earnings / Revenue | 15.01% | 12.68% | 63.58% |
| Basic Earnings Per Share | $0.08 | $0.09 | $0.30 |
| Diluted Earnings Per Share | $0.07 | $0.09 | $0.30 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 20.74M shares | 20.44M shares | 20.26M shares |
| Diluted Shares Outstanding | 21.78M shares | 21.06M shares | 20.43M shares |
Balance Sheet
| Concept | 2014 Q2 | 2013 Q4 | 2013 Q2 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $22.00M | $16.00M | $5.900M |
| YoY Change | 272.88% | 29.03% | -43.27% |
| Cash & Equivalents | $14.54M | $11.64M | $5.923M |
| Short-Term Investments | $7.500M | $4.300M | |
| Other Short-Term Assets | $1.123M | $959.0K | $1.211M |
| YoY Change | -7.27% | 15.68% | 10.09% |
| Inventory | $817.0K | $1.392M | $2.265M |
| Prepaid Expenses | $745.0K | $786.0K | $848.0K |
| Receivables | $3.100M | $2.200M | $700.0K |
| Other Receivables | $800.0K | $4.500M | $4.800M |
| Total Short-Term Assets | $28.59M | $24.88M | $14.57M |
| YoY Change | 96.19% | 4.44% | -30.95% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $619.0K | $867.0K | $804.0K |
| YoY Change | -23.01% | 10.03% | 34.0% |
| Goodwill | $12.24M | $12.24M | $12.24M |
| YoY Change | 0.0% | 0.0% | |
| Intangibles | $51.91M | $53.10M | $54.25M |
| YoY Change | -4.3% | -5.03% | |
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $253.0K | $299.0K | $394.0K |
| YoY Change | -35.79% | -42.17% | -79.26% |
| Total Long-Term Assets | $71.26M | $79.83M | $85.00M |
| YoY Change | -16.16% | -0.75% | 4.04% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $28.59M | $24.88M | $14.57M |
| Total Long-Term Assets | $71.26M | $79.83M | $85.00M |
| Total Assets | $99.85M | $104.7M | $99.57M |
| YoY Change | 0.28% | 0.43% | -3.14% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $5.059M | $3.951M | $4.755M |
| YoY Change | 6.39% | -32.51% | -29.03% |
| Accrued Expenses | $3.241M | $5.337M | $4.021M |
| YoY Change | -19.4% | 7.58% | -4.26% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| Long-Term Debt Due | $5.400M | $11.90M | $16.50M |
| YoY Change | -67.27% | -33.52% | 85.39% |
| Total Short-Term Liabilities | $18.62M | $28.94M | $32.57M |
| YoY Change | -42.83% | -18.34% | 5.75% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $1.600M | $3.100M | $6.300M |
| YoY Change | -74.6% | -84.02% | -71.62% |
| Other Long-Term Liabilities | $728.0K | $695.0K | $673.0K |
| YoY Change | 8.17% | -36.0% | -97.74% |
| Total Long-Term Liabilities | $728.0K | $695.0K | $673.0K |
| YoY Change | 8.17% | -36.0% | -98.71% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $18.62M | $28.94M | $32.57M |
| Total Long-Term Liabilities | $728.0K | $695.0K | $673.0K |
| Total Liabilities | $36.76M | $55.10M | $60.30M |
| YoY Change | -39.04% | -29.15% | -29.3% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$667.7M | -$671.3M | -$675.2M |
| YoY Change | -1.11% | -1.67% | |
| Common Stock | $21.00K | $21.00K | $21.00K |
| YoY Change | 0.0% | 0.0% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $42.28M | ||
| YoY Change | |||
| Treasury Stock Shares | 1.118M shares | 1.118M shares | |
| Shareholders Equity | $64.17M | $49.61M | $39.27M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $99.85M | $104.7M | $99.57M |
| YoY Change | 0.28% | 0.43% | -3.14% |
Cashflow Statement
| Concept | 2014 Q2 | 2013 Q4 | 2013 Q2 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $1.592M | $1.869M | $6.091M |
| YoY Change | -73.86% | 75.82% | -340.85% |
| Depreciation, Depletion And Amortization | $669.0K | $700.0K | $669.0K |
| YoY Change | 0.0% | 0.0% | -1.33% |
| Cash From Operating Activities | $4.000M | $12.00M | $6.900M |
| YoY Change | -42.03% | 445.45% | -1085.71% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $0.00 | -$100.0K | -$3.700M |
| YoY Change | -100.0% | 1133.33% | |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $600.0K | -$900.0K | $0.00 |
| YoY Change | 800.0% | ||
| Cash From Investing Activities | $600.0K | -$1.000M | -$3.700M |
| YoY Change | -116.22% | 1750.0% | |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -3.100M | -2.700M | -2.300M |
| YoY Change | 34.78% | -184.37% | |
| NET CHANGE | |||
| Cash From Operating Activities | 4.000M | 12.00M | 6.900M |
| Cash From Investing Activities | 600.0K | -1.000M | -3.700M |
| Cash From Financing Activities | -3.100M | -2.700M | -2.300M |
| Net Change In Cash | 1.500M | 8.300M | 900.0K |
| YoY Change | 66.67% | 53.7% | -200.0% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $4.000M | $12.00M | $6.900M |
| Capital Expenditures | $0.00 | -$100.0K | -$3.700M |
| Free Cash Flow | $4.000M | $12.10M | $10.60M |
| YoY Change | -62.26% | 450.0% | -2750.0% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2013Q4 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
173000 | USD |
| CY2014Q2 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
378000 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3951000 | USD |
| CY2014Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
5059000 | USD |
| CY2014Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3241000 | USD |
| CY2013Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
5337000 | USD |
| CY2014Q2 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
279000 | USD |
| CY2013Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
697000 | USD |
| CY2014Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2794000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3873000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
2914000 | USD |
| CY2014Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
5041000 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
718017000 | USD |
| CY2014Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
726758000 | USD |
| us-gaap |
Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
|
5093000 | USD | |
| us-gaap |
Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
|
2616000 | USD | |
| CY2014Q2 | us-gaap |
Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
|
3027000 | USD |
| CY2013Q2 | us-gaap |
Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
|
1492000 | USD |
| CY2014Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | USD |
| CY2013Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | USD |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1200000 | USD | |
| CY2014Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
600000 | USD |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1100000 | shares | |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
400000 | shares | |
| us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
-16000 | USD | |
| us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | USD | |
| CY2014Q2 | us-gaap |
Assets
Assets
|
99847000 | USD |
| CY2013Q4 | us-gaap |
Assets
Assets
|
104713000 | USD |
| CY2014Q2 | us-gaap |
Assets Current
AssetsCurrent
|
28585000 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
24881000 | USD |
| CY2014Q2 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
-5079000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
-2914000 | USD |
| CY2014Q2 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
3710000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
2767000 | USD |
| CY2014Q2 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
-38000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
0 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
5681000 | USD |
| CY2014Q2 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
8751000 | USD |
| CY2014Q2 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
|
-1312000 | USD |
| us-gaap |
Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
|
-3260000 | USD | |
| CY2013Q2 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
|
2741000 | USD |
| us-gaap |
Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
|
900000 | USD | |
| us-gaap |
Business Exit Costs1
BusinessExitCosts1
|
340000 | USD | |
| us-gaap |
Business Exit Costs1
BusinessExitCosts1
|
132000 | USD | |
| CY2013Q2 | us-gaap |
Business Exit Costs1
BusinessExitCosts1
|
44000 | USD |
| CY2014Q2 | us-gaap |
Business Exit Costs1
BusinessExitCosts1
|
136000 | USD |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11639000 | USD |
| CY2014Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
14537000 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
12381000 | USD |
| CY2013Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5923000 | USD |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
2898000 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-6458000 | USD | |
| CY2014Q2 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | USD |
| us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-642000 | USD | |
| us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
0 | USD | |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
33333333 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
33333333 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
20468521 | shares |
| CY2014Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
20778526 | shares |
| CY2014Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
20778526 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
20468521 | shares |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
21000 | USD |
| CY2014Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
21000 | USD |
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
5815000 | USD | |
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
8981000 | USD | |
| CY2013Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
6320000 | USD |
| CY2014Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-4309000 | USD |
| us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations of Credit Risk</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash equivalents, investments and accounts receivable.</font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company invests its excess cash principally in U.S. government debt securities, investment-grade corporate debt securities and certificates of deposit. The Company has established guidelines relative to diversification and maturities that maintain safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates. The Company did not experience any significant losses on its cash equivalents, short-term investments or restricted investments for the periods ending </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June 30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June 30, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font><font style="font-family:inherit;font-size:10pt;">, cash deposits held at financial institutions in excess of FDIC insured amounts of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$250,000</font><font style="font-family:inherit;font-size:10pt;"> were approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$13.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$11.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> customer was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">92%</font><font style="font-family:inherit;font-size:10pt;"> of total accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June 30, 2014</font><font style="font-family:inherit;font-size:10pt;">, the majority of which has been received. Accounts receivable from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> customers was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">75%</font><font style="font-family:inherit;font-size:10pt;"> of total accounts receivable at </font><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font><font style="font-family:inherit;font-size:10pt;">.  </font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company currently obtains Captisol from a single supplier.  If this supplier were not able to supply the requested amounts of Captisol and the existing inventory was depleted, the Company would be unable to continue to derive revenues from the sale of Captisol until it obtained an alternative source, which might take a considerable length of time. The Company maintains inventory of Captisol, which has a </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> year shelf life, at </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> geographically spread storage locations in the United States and Europe.  If disasters were to strike one or all three of these locations, it could lead to supply interruptions. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> | ||
| CY2014Q2 | us-gaap |
Contractual Obligation
ContractualObligation
|
11812000 | USD |
| us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
3637000 | USD | |
| CY2013Q2 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
1214000 | USD |
| CY2014Q2 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
1186000 | USD |
| us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
1877000 | USD | |
| CY2014Q2 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
343000 | USD |
| CY2013Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
350000 | USD |
| CY2014Q2 | us-gaap |
Deferred Revenue
DeferredRevenue
|
0 | USD |
| CY2013Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
100000 | USD |
| CY2013Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
116000 | USD |
| CY2014Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
92000 | USD |
| CY2014Q2 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
2085000 | USD |
| CY2013Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
2085000 | USD |
| CY2014Q2 | us-gaap |
Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
|
1574000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
|
1574000 | USD |
| CY2014Q2 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
1104000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
1098000 | USD |
| us-gaap |
Depreciation
Depreciation
|
200000 | USD | |
| us-gaap |
Depreciation
Depreciation
|
100000 | USD | |
| CY2013Q2 | us-gaap |
Depreciation
Depreciation
|
100000 | USD |
| CY2014Q2 | us-gaap |
Depreciation
Depreciation
|
100000 | USD |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1339000 | USD | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1337000 | USD | |
| CY2014Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
669000 | USD |
| CY2013Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
669000 | USD |
| us-gaap |
Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
|
2588000 | USD | |
| CY2014Q2 | us-gaap |
Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
|
0 | USD |
| CY2013Q2 | us-gaap |
Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
|
2397000 | USD |
| us-gaap |
Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
|
0 | USD | |
| us-gaap |
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
|
2588000 | USD | |
| CY2014Q2 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
|
0 | USD |
| us-gaap |
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
|
0 | USD | |
| CY2013Q2 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
|
2397000 | USD |
| CY2013Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.30 | |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.18 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.38 | ||
| CY2014Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.08 | |
| CY2013Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.30 | |
| CY2014Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.07 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.37 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.17 | ||
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1929000 | USD |
| CY2014Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1123000 | USD |
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
|
631000 | USD | |
| CY2014Q2 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
804000 | USD |
| CY2013Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
11746000 | USD |
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
|
1668000 | USD | |
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
|
631000 | USD | |
| CY2013Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
21057000 | USD |
| CY2014Q2 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
11179000 | USD |
| us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P20Y | ||
| CY2014Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
2400000 | USD |
| CY2014Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
2400000 | USD |
| CY2014Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
2400000 | USD |
| CY2014Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
2400000 | USD |
| CY2014Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
2400000 | USD |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
10310000 | USD | |
| CY2013Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4306000 | USD |
| CY2014Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5239000 | USD |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8808000 | USD | |
| CY2013Q4 | us-gaap |
Goodwill
Goodwill
|
12238000 | USD |
| CY2014Q2 | us-gaap |
Goodwill
Goodwill
|
12238000 | USD |
| us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
3688000 | USD | |
| CY2013Q2 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
3694000 | USD |
| us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
4998000 | USD | |
| CY2014Q2 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
1592000 | USD |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
3390000 | USD | |
| CY2014Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
1241000 | USD |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
5174000 | USD | |
| CY2013Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
3804000 | USD |
| us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
3384000 | USD | |
| us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
4998000 | USD | |
| CY2013Q2 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
3694000 | USD |
| CY2014Q2 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
1288000 | USD |
| us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.18 | ||
| CY2014Q2 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.08 | |
| CY2013Q2 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.18 | |
| us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.25 | ||
| us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.17 | ||
| CY2014Q2 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.07 | |
| us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.24 | ||
| CY2013Q2 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.18 | |
| CY2014Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
USD | |
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
2588000 | USD | |
| CY2013Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
2397000 | USD |
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | USD | |
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.00 | ||
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.13 | ||
| CY2014Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.00 | |
| CY2013Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.12 | |
| CY2014Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0.00 | |
| CY2013Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0.12 | |
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0.13 | ||
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0.00 | ||
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
6000 | USD | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
176000 | USD | |
| CY2013Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
110000 | USD |
| CY2014Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-47000 | USD |
| us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
3000 | USD | |
| us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-3006000 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-3743000 | USD | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
911000 | USD | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-3890000 | USD | |
| us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-176000 | USD | |
| us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
-6000 | USD | |
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-24000 | USD | |
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-318000 | USD | |
| us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
225000 | USD | |
| us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
169000 | USD | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-575000 | USD | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-429000 | USD | |
| us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-123000 | USD | |
| us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
231000 | USD | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
136000 | USD | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
382000 | USD | |
| CY2013Q2 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
122351 | shares |
| us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
18265 | shares | |
| CY2014Q2 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1012706 | shares |
| us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1063200 | shares | |
| CY2014Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
51911000 | USD |
| CY2013Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
53099000 | USD |
| CY2013Q4 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
65337000 | USD |
| CY2014Q2 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
64149000 | USD |
| us-gaap |
Interest Expense
InterestExpense
|
1361000 | USD | |
| CY2013Q2 | us-gaap |
Interest Expense
InterestExpense
|
453000 | USD |
| us-gaap |
Interest Expense
InterestExpense
|
429000 | USD | |
| CY2014Q2 | us-gaap |
Interest Expense
InterestExpense
|
181000 | USD |
| us-gaap |
Interest Paid
InterestPaid
|
212000 | USD | |
| us-gaap |
Interest Paid
InterestPaid
|
1245000 | USD | |
| CY2014Q2 | us-gaap |
Inventory Net
InventoryNet
|
817000 | USD |
| CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
1392000 | USD |
| us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | USD | |
| us-gaap |
Inventory Write Down
InventoryWriteDown
|
997000 | USD | |
| us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
400000 | USD | |
| CY2013Q2 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
200000 | USD |
| CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
55100000 | USD |
| CY2014Q2 | us-gaap |
Liabilities
Liabilities
|
36761000 | USD |
| CY2014Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
99847000 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
104713000 | USD |
| CY2014Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
18621000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
28939000 | USD |
| CY2013Q1 | us-gaap |
Line Of Credit Facility Periodic Payment
LineOfCreditFacilityPeriodicPayment
|
400000 | USD |
| CY2014Q2 | us-gaap |
Minority Interest
MinorityInterest
|
-1084000 | USD |
| CY2013Q4 | us-gaap |
Minority Interest
MinorityInterest
|
0 | USD |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-11747000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3299000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-388000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3726000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
6585000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
9015000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
9657000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
6585000 | USD | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
3688000 | USD | |
| CY2014Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1592000 | USD |
| CY2013Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
6091000 | USD |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-273000 | USD | |
| us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
0 | USD | |
| CY2013Q2 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
0 | USD |
| us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-304000 | USD | |
| CY2014Q2 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-304000 | USD |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
7586000 | USD | |
| CY2014Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-117000 | USD |
| us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
20108000 | USD | |
| CY2014Q2 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
9250000 | USD |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5821000 | USD | |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-3068000 | USD | |
| CY2013Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2290000 | USD |
| CY2013Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
9109000 | USD |
| CY2014Q2 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
2698000 | USD |
| us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | segment | |
| CY2014Q2 | us-gaap |
Number Of Stores
NumberOfStores
|
3 | storage_location |
| us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
15784000 | USD | |
| CY2013Q2 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
8066000 | USD |
| CY2013Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1514000 | USD |
| CY2014Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1358000 | USD |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
5447000 | USD | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
6458000 | USD | |
| CY2014Q2 | us-gaap |
Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
|
9769000 | USD |
| us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
1800000 | USD | |
| CY2013Q2 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
900000 | USD |
| CY2014Q2 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
900000 | USD |
| us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
1900000 | USD | |
| CY2013Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
2711000 | USD |
| CY2014Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1839000 | USD |
| CY2014Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
1123000 | USD |
| CY2013Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
959000 | USD |
| CY2014Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
253000 | USD |
| CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
299000 | USD |
| CY2013Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
229000 | USD |
| CY2014Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-5127000 | USD |
| us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
1395000 | USD | |
| us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
3095000 | USD | |
| CY2014Q2 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
774000 | USD |
| CY2013Q2 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
0 | USD |
| us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
0 | USD | |
| us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
968000 | USD | |
| us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
0 | USD | |
| CY2014Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
0 | USD |
| CY2013Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
0 | USD |
| us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
0 | USD | |
| CY2014Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
728000 | USD |
| CY2013Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
695000 | USD |
| us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
13000 | USD | |
| us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
0 | USD | |
| CY2014Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1376000 | USD |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
188000 | USD | |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
621000 | USD | |
| CY2013Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
2000 | USD |
| us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
1000 | USD | |
| us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
158000 | USD | |
| us-gaap |
Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
|
-3000 | USD | |
| us-gaap |
Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
|
-125000 | USD | |
| CY2013Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
786000 | USD |
| CY2014Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
745000 | USD |
| us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
0 | USD | |
| us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
1156000 | USD | |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
3648000 | USD | |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
1186000 | USD | |
| us-gaap |
Profit Loss
ProfitLoss
|
7586000 | USD | |
| CY2014Q2 | us-gaap |
Profit Loss
ProfitLoss
|
1288000 | USD |
| us-gaap |
Profit Loss
ProfitLoss
|
3384000 | USD | |
| CY2013Q2 | us-gaap |
Profit Loss
ProfitLoss
|
6091000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
4740000 | USD |
| CY2014Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3413000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
867000 | USD |
| CY2014Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
619000 | USD |
| us-gaap |
Realized Investment Gains Losses
RealizedInvestmentGainsLosses
|
0 | USD | |
| us-gaap |
Realized Investment Gains Losses
RealizedInvestmentGainsLosses
|
968000 | USD | |
| CY2013Q4 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
2222000 | USD |
| CY2014Q2 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
3133000 | USD |
| CY2013Q1 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
7000000 | USD |
| us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
12933000 | USD | |
| us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
6947000 | USD | |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4487000 | USD | |
| CY2013Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2022000 | USD |
| CY2014Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2689000 | USD |
| CY2013Q4 | us-gaap |
Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
|
1341000 | USD |
| CY2014Q2 | us-gaap |
Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
|
1261000 | USD |
| CY2014Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-667650000 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-671339000 | USD |
| us-gaap |
Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Milestone Payments</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the Company entered into a licensing agreement and research collaboration with Omthera Pharmaceuticals. The research collaboration will target the development of novel products that utilize the proprietary Ligand-developed LTP TECHNOLOGY™ to improve lipid-lowering activity of certain omega-3 fatty acids. The Company is eligible to receive development, regulatory, and event-based payments, of which the Company determined a </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> payment upon completion of a proof of concept under the development program represents a milestone under the milestone method of accounting as (1) it is an event that can only be achieved in part on the Company's past performance, (2) there is substantive uncertainty at the date the arrangement was entered into that the event will be achieved and (3) it results in additional payment being due to us. None of the other event-based payments represents a milestone under the milestone method of accounting. No event based payment or milestone was achieved during the periods presented.</font></div></div> | ||
| us-gaap |
Revenue Recognition Sales Returns
RevenueRecognitionSalesReturns
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Product Returns</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the sale of the Avinza and Oncology product lines, the Company retained the obligation for returns of product that were shipped to wholesalers prior to the close of the transactions. The accruals for product returns, which were recorded as part of the accounting for the sales transactions, are based on historical experience. Any subsequent changes to the Company’s estimate of product returns are accounted for as a component of discontinued operations.</font></div></div> | ||
| us-gaap |
Revenue Recognition Services Royalty Fees
RevenueRecognitionServicesRoyaltyFees
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Sale of Royalty Rights</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company previously sold to third parties the rights to future royalties of certain of its products. As part of the underlying royalty agreements, the partners have the right to offset a portion of any future royalty payments owed to the Company to the extent of previous milestone payments. Accordingly, the Company deferred a portion of the revenue associated with each tranche of royalty right sold, equal to the pro-rata share of the potential royalty offset. Such amounts associated with the offset rights against future royalty payments will be recognized as revenue upon receipt of future royalties from the respective partners. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June 30, 2014</font><font style="font-family:inherit;font-size:10pt;"> there was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> deferred revenue remaining related to the sale of royalty rights. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font><font style="font-family:inherit;font-size:10pt;">, the Company had deferred </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> of revenue related to the sale of royalty rights. </font></div></div> | ||
| CY2014Q2 | us-gaap |
Revenues
Revenues
|
10608000 | USD |
| us-gaap |
Revenues
Revenues
|
21231000 | USD | |
| CY2013Q2 | us-gaap |
Revenues
Revenues
|
9580000 | USD |
| us-gaap |
Revenues
Revenues
|
26566000 | USD | |
| us-gaap |
Royalty Revenue
RoyaltyRevenue
|
10742000 | USD | |
| us-gaap |
Royalty Revenue
RoyaltyRevenue
|
13091000 | USD | |
| CY2014Q2 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
5241000 | USD |
| CY2013Q2 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
4916000 | USD |
| CY2013Q2 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
3993000 | USD |
| us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
9191000 | USD | |
| CY2014Q2 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
3476000 | USD |
| us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
5532000 | USD | |
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.69 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.69 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5093000 | USD | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2616000 | USD | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | ||
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | ||
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
||
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.67 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.69 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.013 | ||
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.019 | |
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.014 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.019 | ||
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
945222 | shares |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
16.30 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
3814 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
49967 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
366184 | shares | |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
66386000 | USD |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
62705000 | USD |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1825183 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1746709 | shares |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
28.23 | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
16.79 | |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
66386000 | USD |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
1825183 | shares |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
28.23 | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
15.72 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
84.38 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
16.69 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
73.81 | ||
| CY2013Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y3M18D | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y3M18D | ||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y5M9D | ||
| CY2014Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y4M21D | |
| CY2014Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
43474000 | USD |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y9M11D | ||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y8M12D | ||
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y6M26D | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P7Y8M12D | ||
| CY2013Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
4340000 | USD |
| CY2014Q2 | us-gaap |
Short Term Investments
ShortTermInvestments
|
7490000 | USD |
| us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
233929 | shares | |
| CY2014Q2 | us-gaap |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
5000000 | USD |
| CY2014Q2 | us-gaap |
Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
|
P1Y | |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
49613000 | USD |
| CY2014Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
64170000 | USD |
| CY2013Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
1118222 | shares |
| us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
1395000 | USD | |
| us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
3095000 | USD | |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires the use of estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, contingent assets and liabilities, definite and indefinite lived intangible assets, goodwill, co-promote termination payments receivable and co-promote termination liabilities, uncertain tax positions, deferred revenue, lease exit liability and income tax net operating loss carryforwards during the reporting period. The Company’s critical accounting policies are those that are both most important to the Company’s financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the condensed consolidated financial statements, actual results may materially vary from these estimates.</font></div></div> | ||
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
21776125 | shares | |
| CY2013Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
20427360 | shares |
| CY2014Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
21780034 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
20277763 | shares | |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
20668110 | shares | |
| CY2014Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
20738299 | shares |
| CY2013Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
20258618 | shares |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
20223634 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
20223634 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
20668110 | shares | |
| CY2013Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
20258618 | shares |
| CY2014Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
20738299 | shares |
| us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
44815 | shares | |
| CY2013Q2 | us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
46391 | shares |
| CY2014Q2 | us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
29029 | shares |
| us-gaap |
Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
|
35864 | shares | |
| CY2014Q2 | lgnd |
Capitalized Initial Public Offering Expenses
CapitalizedInitialPublicOfferingExpenses
|
1094000 | USD |
| CY2013Q4 | lgnd |
Capitalized Initial Public Offering Expenses
CapitalizedInitialPublicOfferingExpenses
|
0 | USD |
| CY2013Q4 | lgnd |
Cash Deposits In Excess Of Fdic Insured Amount
CashDepositsInExcessOfFdicInsuredAmount
|
11100000 | USD |
| CY2014Q2 | lgnd |
Cash Deposits In Excess Of Fdic Insured Amount
CashDepositsInExcessOfFdicInsuredAmount
|
13900000 | USD |
| CY2013Q4 | lgnd |
Co Promote Termination Liability Current
CoPromoteTerminationLiabilityCurrent
|
4329000 | USD |
| CY2014Q2 | lgnd |
Co Promote Termination Liability Current
CoPromoteTerminationLiabilityCurrent
|
391000 | USD |
| CY2013Q4 | lgnd |
Co Promote Termination Liability Noncurrent
CoPromoteTerminationLiabilityNoncurrent
|
7417000 | USD |
| CY2014Q2 | lgnd |
Co Promote Termination Liability Noncurrent
CoPromoteTerminationLiabilityNoncurrent
|
413000 | USD |
| CY2014Q2 | lgnd |
Co Promote Termination Payments Receivable Current
CoPromoteTerminationPaymentsReceivableCurrent
|
391000 | USD |
| CY2013Q4 | lgnd |
Co Promote Termination Payments Receivable Current
CoPromoteTerminationPaymentsReceivableCurrent
|
4329000 | USD |
| CY2013Q4 | lgnd |
Co Promote Termination Payments Receivable Noncurrent
CoPromoteTerminationPaymentsReceivableNoncurrent
|
7417000 | USD |
| CY2014Q2 | lgnd |
Co Promote Termination Payments Receivable Noncurrent
CoPromoteTerminationPaymentsReceivableNoncurrent
|
413000 | USD |
| lgnd |
Co Promotion Agreement Termination Assumed Payments Made By Assignee
CoPromotionAgreementTerminationAssumedPaymentsMadeByAssignee
|
631000 | USD | |
| lgnd |
Co Promotion Agreement Termination Fair Value Adjustments
CoPromotionAgreementTerminationFairValueAdjustments
|
10311000 | USD | |
| CY2014Q2 | lgnd |
Co Promotion Agreement Termination Liability
CoPromotionAgreementTerminationLiability
|
804000 | USD |
| CY2013Q4 | lgnd |
Co Promotion Agreement Termination Liability
CoPromotionAgreementTerminationLiability
|
11746000 | USD |
| CY2014Q2 | lgnd |
Co Promotion Agreement Termination Liability Current
CoPromotionAgreementTerminationLiabilityCurrent
|
391000 | USD |
| CY2014Q2 | lgnd |
Co Promotion Agreement Termination Liability Noncurrent
CoPromotionAgreementTerminationLiabilityNoncurrent
|
413000 | USD |
| lgnd |
Collaborative Research And Development And Other Revenues
CollaborativeResearchAndDevelopmentAndOtherRevenues
|
4957000 | USD | |
| CY2014Q2 | lgnd |
Collaborative Research And Development And Other Revenues
CollaborativeResearchAndDevelopmentAndOtherRevenues
|
1891000 | USD |
| lgnd |
Collaborative Research And Development And Other Revenues
CollaborativeResearchAndDevelopmentAndOtherRevenues
|
4284000 | USD | |
| CY2013Q2 | lgnd |
Collaborative Research And Development And Other Revenues
CollaborativeResearchAndDevelopmentAndOtherRevenues
|
671000 | USD |
| CY2013Q4 | lgnd |
Commercial License Rights
CommercialLicenseRights
|
4571000 | USD |
| CY2014Q2 | lgnd |
Commercial License Rights
CommercialLicenseRights
|
4567000 | USD |
| CY2013Q4 | lgnd |
Current Portion Of Liability For Contingent Value Rights
CurrentPortionOfLiabilityForContingentValueRights
|
1712000 | USD |
| CY2014Q2 | lgnd |
Deposits Liabilities Noncurrent
DepositsLiabilitiesNoncurrent
|
385000 | USD |
| CY2014Q2 | lgnd |
Current Portion Of Liability For Contingent Value Rights
CurrentPortionOfLiabilityForContingentValueRights
|
2877000 | USD |
| CY2013Q4 | lgnd |
Deposits Liabilities Noncurrent
DepositsLiabilitiesNoncurrent
|
345000 | USD |
| lgnd |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Fair Value Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetFairValueAdjustment
|
-10311000 | USD | |
| lgnd |
Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Fair Value Adjustment Co Promotion Termination
FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentCoPromotionTermination
|
-10311000 | USD | |
| lgnd |
Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Fair Value Adjustment Contingent Liabilities
FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustmentContingentLiabilities
|
2732000 | USD | |
| lgnd |
Lease Expiration Year Maximum
LeaseExpirationYearMaximum
|
2019 | ||
| lgnd |
Lease Expiration Year Minimum
LeaseExpirationYearMinimum
|
2014 | ||
| CY2014Q2 | lgnd |
Liability For Contingent Value Rights
LiabilityForContingentValueRights
|
12223000 | USD |
| CY2013Q4 | lgnd |
Liability For Contingent Value Rights
LiabilityForContingentValueRights
|
11795000 | USD |
| lgnd |
Liabilityfor Commercial License Rights
LiabilityforCommercialLicenseRights
|
0 | USD | |
| lgnd |
Liabilityfor Commercial License Rights
LiabilityforCommercialLicenseRights
|
1000000 | USD | |
| CY2013Q1 | lgnd |
Line Of Credit Facility Additional Payment On Borrowings Percentage
LineOfCreditFacilityAdditionalPaymentOnBorrowingsPercentage
|
0.06 | |
| CY2013Q1 | lgnd |
Line Of Credit Facility Prepayment Amount
LineOfCreditFacilityPrepaymentAmount
|
100000 | USD |
| CY2013Q1 | lgnd |
Line Of Credit Facility Prepayment Fee Percentage
LineOfCreditFacilityPrepaymentFeePercentage
|
0.01 | |
| CY2013Q4 | lgnd |
Long Term Portion Of Lease Exit Obligations
LongTermPortionOfLeaseExitObligations
|
3071000 | USD |
| CY2014Q2 | lgnd |
Long Term Portion Of Lease Exit Obligations
LongTermPortionOfLeaseExitObligations
|
1587000 | USD |
| lgnd |
Maturity Period Of Highly Liquid Securities Maximum
MaturityPeriodOfHighlyLiquidSecuritiesMaximum
|
P3M | ||
| lgnd |
Maximum Period For Accounts Receivable Outstanding To Be Considered As Past Due
MaximumPeriodForAccountsReceivableOutstandingToBeConsideredAsPastDue
|
P90D | ||
| lgnd |
Minimum Period For Accounts Receivable Outstanding To Be Considered As Past Due
MinimumPeriodForAccountsReceivableOutstandingToBeConsideredAsPastDue
|
P30D | ||
| lgnd |
Non Cash Change In Estimated Fair Value Of Contingent Value Rights
NonCashChangeInEstimatedFairValueOfContingentValueRights
|
-3261000 | USD | |
| lgnd |
Non Cash Change In Estimated Fair Value Of Contingent Value Rights
NonCashChangeInEstimatedFairValueOfContingentValueRights
|
900000 | USD | |
| lgnd |
Non Restricted Equity And Debt Securities With Maturity Period
NonRestrictedEquityAndDebtSecuritiesWithMaturityPeriod
|
P3M | ||
| lgnd |
Noncash Upfront Fee
NoncashUpfrontFee
|
1211000 | USD | |
| lgnd |
Noncash Upfront Fee
NoncashUpfrontFee
|
0 | USD | |
| CY2014Q2 | lgnd |
Number Of Drugs Included In Product Line
NumberOfDrugsIncludedInProductLine
|
4 | drug |
| CY2013Q2 | lgnd |
Operating Lease Adjustment For Accretion And Changes In Lease Assumptions
OperatingLeaseAdjustmentForAccretionAndChangesInLeaseAssumptions
|
200000 | USD |
| CY2014Q2 | lgnd |
Operating Lease Adjustment For Accretion And Changes In Lease Assumptions
OperatingLeaseAdjustmentForAccretionAndChangesInLeaseAssumptions
|
100000 | USD |
| CY2014Q2 | lgnd |
Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate Maximum
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateMaximum
|
0.035 | |
| CY2014Q2 | lgnd |
Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate Minimum
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateMinimum
|
0.03 | |
| lgnd |
Payments To Contingent Value Right Holders
PaymentsToContingentValueRightHolders
|
0 | USD | |
| lgnd |
Payments To Contingent Value Right Holders
PaymentsToContingentValueRightHolders
|
1668000 | USD | |
| lgnd |
Period Allowed For Return Of Products Maximum
PeriodAllowedForReturnOfProductsMaximum
|
P90D | ||
| lgnd |
Period Allowed For Return Of Products Minimum
PeriodAllowedForReturnOfProductsMinimum
|
P30D | ||
| lgnd |
Period For Which Available Resources Are Sufficient To Satisfy Anticipated Operating And Capital Requirements
PeriodForWhichAvailableResourcesAreSufficientToSatisfyAnticipatedOperatingAndCapitalRequirements
|
P12M | ||
| lgnd |
Product Shelf Life
ProductShelfLife
|
P5Y | ||
| lgnd |
Purchasefor Commercial License Rights
PurchaseforCommercialLicenseRights
|
3571000 | USD | |
| lgnd |
Purchasefor Commercial License Rights
PurchaseforCommercialLicenseRights
|
0 | USD | |
| CY2013Q2 | lgnd |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate
|
0.084 | |
| CY2014Q2 | lgnd |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate
|
0.086 | |
| CY2013Q4 | lgnd |
Short Term Portion Of Lease Exit Obligations
ShortTermPortionOfLeaseExitObligations
|
2811000 | USD |
| CY2014Q2 | lgnd |
Short Term Portion Of Lease Exit Obligations
ShortTermPortionOfLeaseExitObligations
|
2689000 | USD |
| CY2014Q2 | lgnd |
Working Capital
WorkingCapital
|
10000000 | USD |
| CY2014Q2 | lgnd |
Writeoffof In Process Researchand Development
WriteoffofInProcessResearchandDevelopment
|
0 | USD |
| lgnd |
Writeoffof In Process Researchand Development
WriteoffofInProcessResearchandDevelopment
|
480000 | USD | |
| lgnd |
Writeoffof In Process Researchand Development
WriteoffofInProcessResearchandDevelopment
|
0 | USD | |
| CY2013Q2 | lgnd |
Writeoffof In Process Researchand Development
WriteoffofInProcessResearchandDevelopment
|
480000 | USD |
| dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | ||
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
| dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
| dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-06-30 | ||
| dei |
Document Type
DocumentType
|
10-Q | ||
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000886163 | ||
| CY2014Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
20780756 | shares |
| dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | ||
| dei |
Entity Registrant Name
EntityRegistrantName
|
LIGAND PHARMACEUTICALS INC |
